Kolon TissueGene, Inc.
6 clinical trials · Sponsor
◉ Watch Kolon TissueGene, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease (NCT06144970) | Kolon TissueGene, Inc. | 2027-01-19 |
| A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis (NCT05276011) | Kolon TissueGene, Inc. | 2026-10-01 |
| Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee (NCT03291470) | Kolon TissueGene, Inc. | 2021-12-09 |
| A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee (NCT03203330) | Kolon TissueGene, Inc. | 2018-10-30 |
Track Kolon TissueGene, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.